| Literature DB >> 35212466 |
Roger Riera1, Jana Tauler1,2, Natàlia Feiner-Gracia1, Salvador Borrós2, Cristina Fornaguera2, Lorenzo Albertazzi1,3.
Abstract
Nanomedicine emerged some decades ago with the hope to be the solution for most unmet medical needs. However, tracking materials at nanoscale is challenging to their reduced size, below the resolution limit of most conventional techniques. In this context, we propose the use of direct stochastic optical reconstruction microscopy (dSTORM) to study time stability and cell trafficking after transfection of oligopeptide end-modified poly(β-aminoester) (OM-pBAE) nanoparticles. We selected different combinations of cationic end oligopeptides (arginine - R; histidine - H; and lysine - K) among polymer libraries, since the oligopeptide combination demonstrated to be useful for different applications, such as vaccination and gene silencing. We demonstrate that their time evolution as well as their cell uptake and trafficking are dependent on the oligopeptide. This study opens the pave to broad mechanistic studies at nanoscale that could enable a rational selection of specific pBAE nanoparticles composition after determining their stability and cell trafficking.Entities:
Keywords: cell trafficking; direct stochastic optical reconstruction microscopy (dSTORM); nanoparticle stability; poly(β-aminoester) nanoparticles
Mesh:
Substances:
Year: 2022 PMID: 35212466 PMCID: PMC9400995 DOI: 10.1002/cmdc.202100633
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.540
Figure 1Polyplex formulation and STORM imaging. a) Polyplex formulation consists on combining pDNA with a mixture of two of arginine (R), lysine (K) or histidine (H) polymers. b) Schematic representation of polyplex cellular trafficking and STORM imaging. c) STORM images of polyplexes on a glass show the increased resolution compared to the conventional low‐resolution TIRF image. d‐e) STORM images of RK polyplexes ‐ d) labelling polymer R and e) labelling polymer K ‐ on a glass slide show the separate labelling strategy of R and K polymers. Scale bars: 1 μm (c), 200 nm (d–e).
Polyplex mixture formulations and labelling strategies.
|
Nanoparticle type |
Given name |
Polymers combination |
Labelling |
|---|---|---|---|
|
KH |
KH*/pDNA* |
60 % K 40 % H |
Cy3 : pGFP Cy5 : H |
|
KH |
K*H/pDNA* |
60 % K 40 % H |
Cy3 : pGFP Cy5 : K |
|
RH |
RH*/pDNA* |
60 % R 40 % H |
Cy3 : pGFP Cy5 : H |
|
RH |
R*H/pDNA* |
60 % R 40 % H |
Cy3 : pGFP Cy5 : R |
|
RK |
R*K/pDNA* |
50 % R 50 % K |
Cy3 : pGFP Cy5 : R |
|
RK |
RK*/pDNA* |
50 % R 50 % K |
Cy3 : pGFP Cy5 : K |
Figure 2STORM images of time evolution of polyplexes inside the cell. Labelling corresponds to the polymer (red) and the pDNA (green). Each image corresponds to an individual cell. White square on STORM images is zoomed on the images on the right. Scale bars on brightfield and STORM images are 5 μm and on zoom ins 500 nm.
Figure 3Polyplex decomplexation quantification. a) Analysis workflow of polyplex decomplexation quantification. A detailed description of the analysis procedure can be found on the Experimental section b) pDNA and pBAE (R) localizations of RH polyplexes at 0 (top) and 12 hours (bottom). c) Median values of pDNA (green triangle), K (strong red square), R (red rhombus) and H (light red circle) polymer of RK, RH and KH polyplexes. The distribution of each individual time point can be found on Figures S3–5. Frequencies of each polyplex ratios between polymer and pDNA localizations detailed in Figure 4 and Figures S6‐7.
Figure 4Frequencies of single KH polyplex ratios between polymer and pDNA localizations. Dashed line represents median value of the distribution.